• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7211
Device Problems Deflation Problem (1149); Difficult to Remove (1528); Detachment of Device or Device Component (2907)
Patient Problem Foreign Body In Patient (2687)
Event Date 07/29/2022
Event Type  Injury  
Event Description
It was reported that balloon issues occurred requiring additional intervention to resolve.The target lesion was located in the mildly tortuous and mildly calcified left main/ left anterior descending artery.A 5.50mm x 8mm nc emerge balloon catheter was advanced for dilatation.However, during the procedure, there was trouble in deflating and retracting the device.Eventually, the shaft was removed but the balloon was detached and remained on the guidewire.An attempt was made to buddy wiring and pin the piece with another balloon, but it was unsuccessful.A guidezilla guide extension catheter was then advanced over the proximal portion of the balloon to trap the balloon inside it.At some point during the case, the guidewire on which the broken balloon remained was removed and the balloon remained floating freely inside patient.The physician decided to pin the balloon permanently against the vessel wall with a synergy drug-eluting stent and the procedure was completed.No patient complications were reported.
 
Manufacturer Narrative
Initial reporter address 1: (b)(6).
 
Manufacturer Narrative
E1 - initial reporter address 1: (b)(6).Returned product consisted of an incomplete nc emerge balloon catheter.The device was microscopically and visually examined.There were numerous hypotube and kinks to the device.There was separation of the inflation lumen at 13.7cm from the midshaft bond, which is also the length of the stretched shaft.The full length of the hypotube was returned.The rapid port exchange, distal inflation lumen, full guidewire lumen, markerbands, balloon and tip were not returned for analysis.There was contrast and blood in the inflation lumen.Product analysis could not confirm the reported deflation difficulties, as the balloon was not returned for analysis.However, given the damage to the device, the separation and removal difficulties were confirmed through the analysis as the inflation lumen was separated and the unretrievable fragments of the device indicate procedural and removal difficulties.B5 describe event or problem: corrected.
 
Event Description
It was reported that balloon issues occurred requiring additional intervention to resolve.The target lesion was located in the mildly tortuous and mildly calcified left main/ left anterior descending artery.A 5.50mm x 8mm nc emerge balloon catheter was advanced for dilatation.However, during the procedure, there was trouble in deflating and retracting the device.Eventually, the shaft was removed but the balloon was detached and remained on the guidewire.An attempt was made to buddy wiring and pin the piece with another balloon, but it was unsuccessful.A guidezilla guide extension catheter was then advanced over the proximal portion of the balloon to trap the balloon inside it.At some point during the case, the guidewire on which the broken balloon remained was removed and the balloon remained floating freely inside patient.The physician decided to pin the balloon permanently against the vessel wall with a synergy drug-eluting stent and the procedure was completed.No patient complications were reported.It was also reported that the balloon was pulled negative and double negative.The balloon remained in the patient and appeared deflated.The patient did not experience any symptoms and was stable post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15235677
MDR Text Key297994442
Report Number2124215-2022-29234
Device Sequence Number1
Product Code LOX
UDI-Device Identifier08714729846338
UDI-Public08714729846338
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K141236
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/17/2023
Device Model Number7211
Device Catalogue Number7211
Device Lot Number0028400504
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/22/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/17/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-